AIGH Capital Management
Latest statistics and disclosures from AIGH Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are XBI, GLW, PSNL, SCPH, ARQ, and represent 58.64% of AIGH Capital Management's stock portfolio.
- Added to shares of these 10 stocks: GLW (+$41M), PSNL (+$22M), APPS (+$14M), TARS (+$6.7M), XERS (+$6.2M), ARQ, ELUT, SCPH, MRAM, MX.
- Started 10 new stock positions in GLW, Biomx, MRAM, PSNL, Evoke Pharma, XERS, APPS, MCHX, MX, TARS.
- Reduced shares in these 10 stocks: XBI (-$110M), WDC (-$23M), , , RCAT (-$5.7M), DCTH (-$5.6M), PROF (-$5.5M), ZVRA, MYO, CGTX.
- Sold out of its positions in CGTX, EVOK, INFN, ZVRA, PROF, RCAT, SIMO, VCNX, WDC.
- AIGH Capital Management was a net seller of stock by $-89M.
- AIGH Capital Management has $355M in assets under management (AUM), dropping by 10.19%.
- Central Index Key (CIK): 0001835943
Tip: Access up to 7 years of quarterly data
Positions held by AIGH Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for AIGH Capital Management
AIGH Capital Management holds 39 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 31.1 | $110M | -50% | 500k | 220.89 |
|
| Corning Incorporated (GLW) | 11.5 | $41M | NEW | 900k | 45.15 |
|
| Personalis Ord (PSNL) | 6.1 | $22M | NEW | 4.0M | 5.38 |
|
| Scpharmaceuticals (SCPH) | 5.3 | $19M | +17% | 4.1M | 4.56 |
|
| Advanced Emissions (ARQ) | 4.7 | $17M | +31% | 2.8M | 5.87 |
|
| Delcath Sys Com New (DCTH) | 4.5 | $16M | -25% | 1.8M | 9.03 |
|
| Digital Turbine Com New (APPS) | 3.9 | $14M | NEW | 4.5M | 3.07 |
|
| Myomo Com New (MYO) | 3.1 | $11M | -4% | 2.8M | 4.01 |
|
| Biodesix (BDSX) | 2.9 | $10M | 5.7M | 1.78 |
|
|
| Elutia Cl A Com (ELUT) | 2.7 | $9.6M | +47% | 2.5M | 3.81 |
|
| Cellectar Biosciences Com New (CLRB) | 1.9 | $6.8M | +5% | 3.2M | 2.14 |
|
| Tarsus Pharmaceuticals (TARS) | 1.9 | $6.7M | NEW | 204k | 32.89 |
|
| Tela Bio (TELA) | 1.8 | $6.2M | +49% | 2.5M | 2.53 |
|
| Xeris Pharmaceuticals (XERS) | 1.8 | $6.2M | NEW | 2.2M | 2.85 |
|
| Bk Technologies Corporation Com New (BKTI) | 1.7 | $6.2M | 283k | 21.77 |
|
|
| Electrovaya Com New (ELVA) | 1.6 | $5.8M | -4% | 2.4M | 2.35 |
|
| Ideal Pwr Com New (IPWR) | 1.6 | $5.7M | 700k | 8.20 |
|
|
| Lightpath Technologies Com Cl A (LPTH) | 1.4 | $5.1M | 3.7M | 1.37 |
|
|
| Theratechnologies Com New (THTX) | 1.3 | $4.6M | 3.7M | 1.23 |
|
|
| Eagle Pharmaceuticals (EGRX) | 1.3 | $4.5M | 1.2M | 3.73 |
|
|
| Coya Therapeutics Common Stock (COYA) | 1.2 | $4.2M | 649k | 6.45 |
|
|
| Intellicheck Com New (IDN) | 1.1 | $3.8M | 1.8M | 2.17 |
|
|
| Polypid (PYPD) | 0.7 | $2.4M | +41% | 680k | 3.54 |
|
| Everspin Technologies (MRAM) | 0.6 | $2.2M | NEW | 374k | 5.90 |
|
| Magnachip Semiconductor Corp (MX) | 0.6 | $2.1M | NEW | 450k | 4.67 |
|
| Acasti Pharma Cl A (ACST) | 0.5 | $1.9M | 641k | 3.02 |
|
|
| Franklin Wireless Corporation (FKWL) | 0.5 | $1.8M | 390k | 4.58 |
|
|
| Immix Biopharma (IMMX) | 0.5 | $1.7M | -20% | 1.1M | 1.49 |
|
| Aprea Therapeutics Com New (APRE) | 0.4 | $1.5M | 539k | 2.75 |
|
|
| Beyond Air (XAIR) | 0.4 | $1.4M | 3.6M | 0.38 |
|
|
| Kiora Pharmaceuticals (KPRX) | 0.3 | $935k | 256k | 3.66 |
|
|
| Biomx Com New | 0.2 | $883k | NEW | 865k | 1.02 |
|
| Plus Therapeutics (PSTV) | 0.2 | $819k | 561k | 1.46 |
|
|
| Biofrontera Com New (BFRI) | 0.2 | $667k | 501k | 1.33 |
|
|
| Smartkem Com New (SMTK) | 0.2 | $574k | 135k | 4.26 |
|
|
| In8bio (INAB) | 0.1 | $452k | -21% | 1.7M | 0.27 |
|
| Marchex CL B (MCHX) | 0.1 | $370k | NEW | 198k | 1.87 |
|
| Evoke Pharma | 0.1 | $344k | NEW | 71k | 4.88 |
|
| Saverone 2014 *w Exp 06/02/202 (SVREW) | 0.0 | $46k | 568k | 0.08 |
|
Past Filings by AIGH Capital Management
SEC 13F filings are viewable for AIGH Capital Management going back to 2020
- AIGH Capital Management 2024 Q3 filed Nov. 13, 2024
- AIGH Capital Management 2024 Q2 filed Aug. 7, 2024
- AIGH Capital Management 2024 Q1 filed May 14, 2024
- AIGH Capital Management 2023 Q4 filed Feb. 12, 2024
- AIGH Capital Management 2023 Q3 filed Nov. 13, 2023
- AIGH Capital Management 2023 Q2 filed Aug. 14, 2023
- AIGH Capital Management 2023 Q1 filed May 15, 2023
- AIGH Capital Management 2022 Q4 filed Feb. 15, 2023
- AIGH Capital Management 2022 Q3 filed Nov. 14, 2022
- AIGH Capital Management 2022 Q2 filed Aug. 12, 2022
- AIGH Capital Management 2022 Q1 filed May 12, 2022
- AIGH Capital Management 2021 Q4 filed Feb. 10, 2022
- AIGH Capital Management 2021 Q3 filed Nov. 12, 2021
- AIGH Capital Management 2021 Q2 filed Aug. 12, 2021
- AIGH Capital Management 2021 Q1 filed May 13, 2021
- AIGH Capital Management 2020 Q4 filed Feb. 16, 2021